companiesandmarkets.com

Return to Report | Print

GenVec Inc - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/genvec-inc-premium-company-profile-41353.asp

Report Summary

Introduction

GenVec is a clinical-stage biopharmaceutical company utilizes its proprietary platform, adenovector technology. It's collaborations with National Institute of Health, US Navy and US Department of Agriculture to use its delivery platform to develop vaccines against HIV, influenza, malaria, and foot and mouth disease have established it as potential player in Vaccine market.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    GenVec is a clinical-stage biopharmaceutical company that specializes in using adenovector-based vectors to deliver gene-based therapies for the treatment of various cancers, including pancreatic, head and neck, and rectal cancer.The company's lead candidate, TNFerade, is in Phase II/III clinical trial for the treatment of pancreatic cancer.

    The key elements of the company's business strategy include: advancing the clinical development of its product candidate, TNFerade; continue application of its proprietary adenovector technology to develop new products and strengthening the company's financial and market position through its funded vaccine programs.

    The company's total revenues increased at a CAGR of 22.5% during 2002-2006, from $8.4 million to $18.9 million. This represents an absolute total growth of +$10.5 million for total revenues. The company's only contributor to revenue growth during 2002-2006 was revenues from license, collaboration and others.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    Landmark Products and Services 8
    History 9
    Company Financials 11
    Stock Market Performance 11
    P&L 15
    Balance Sheet 18
    Cash Flow 18
    Business Segment Performance 19
    Products & Services 20
    Pipeline Products 20
    AC Forecast Product Sales 23
    Competitors and Strategic Business Relationships 25
    Key Competitors 25
    Key Suppliers 25
    Key Clients 26
    Shareholding Structure 28
    Strategy 29
    Company View 29
    Corporate Strategy 31
    SWOT Analysis 33
    Overview 33
    Strengths 34
    Weaknesses 36
    Opportunities 37
    Threats 38
    Value Chain Analysis 39
    Overview 39
    Discovery and Product Development 39
    Scorecard 41
    Overview 41
    Scorecard Analysis 42
    Key Employees 43
    List of Key Employees 43
    Key Employee Biographies 44
    Financial and Operational Overview 50
    Financial and Operational Overview 50
    APPENDIX 53
    Ask the analyst 53
    Datamonitor consulting 53
    Disclaimer 53


    TABLE OF FIGURES
    Figure 1: GenVec - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 16


    TABLE OF TABLES
    Table 1: GenVec - Key Facts 6
    Table 2: GenVec - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
    Table 3: GenVec - Key Events Impacting Share Price Performance 12
    Table 4: GenVec - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
    Table 5: GenVec - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 17
    Table 6: GenVec - Balance Sheet, 2002-2006 ($ Mn) 18
    Table 7: GenVec – Cash Flow, 2002-2006 ($ Mn) 18
    Table 8: GenVec - Revenue Breakdown by Division, 2002-2006 ($ Mn) 19
    Table 9: GenVec - In-house Pipeline Products 20
    Table 10: GenVec - Collaboration Products 21
    Table 11: GenVec - Forecast Sales, 2006-2010 ($ Mn) 23
    Table 12: GenVec - Key Competitors 25
    Table 13: GenVec - Key Suppliers 26
    Table 14: GenVec - Key Clients 26
    Table 15: GenVec - Key Shareholders 28
    Table 16: GenVec - SWOT Analysis Summary 33
    Table 17: GenVec - Value Chain Analysis 39
    Table 18: GenVec - Scorecard 41
    Table 19: GenVec - Key Employees 43
    Table 20: GenVec - Financial and Operational Overview 51